Volume 27, Issue 1 supplement | CNS Drugs

Search all CNS Drugs articles

Volume 27, Issue 1 supplement

May 2013

Optimizing Outcomes in Major Depressive Disorder via Augmentation Therapy - Focus on the Role of Atypical Antipsychotics

Issue Editor:

J. Craig Nelson

9 articles in this issue

CNS Drugs Optimizing Outcomes in Major Depressive Disorder via Augmentation Therapy - Focus on the Role of Atypical Antipsychotics

Announcement 05 June 2013 Pages: 1 - 1
Foreword
J. Craig Nelson
Foreword 25 May 2013 Pages: 3 - 4
Challenges in Treating Patients with Major Depressive Disorder: The Impact of Biological and Social Factors
Soichiro Sato
Tzung Lieh Yeh
Review Article 28 May 2013 Pages: 5 - 10
Augmentation Treatments with Second-generation Antipsychotics to Antidepressants in Treatment-resistant Depression
Masaki Kato
Chia-Ming Chang
Review Article 25 May 2013 Pages: 11 - 19
Evidence for the Benefits of Nonantipsychotic Pharmacological Augmentation in the Treatment of Depression
Chia-Ming Chang
Soichiro Sato
Changsu Han
Review Article 28 May 2013 Pages: 21 - 27
Atypical Antipsychotic Augmentation Strategies in the Context of Guideline-based Care for the Treatment of Major Depressive Disorder
Ashwin A. Patkar
Chi-Un Pae
Review Article 25 May 2013 Pages: 29 - 37
Clinical Issues in Use of Atypical Antipsychotics for Depressed Patients
Chi-Un Pae
Ashwin A. Patkar
Review Article 25 May 2013 Pages: 39 - 45
Do We Need to Consider Ethno-cultural Variation in the Use of Atypical Antipsychotics for Asian Patients with Major Depressive Disorder?
Changsu Han
Chi-Un Pae
Review Article 25 May 2013 Pages: 47 - 51
Management of Chronic Depressive Patients with Residual Symptoms
Changsu Han
Tzung Lieh Yeh
Chi-Un Pae
Review Article 25 May 2013 Pages: 53 - 57